文献速递颈动脉与弓上血管

术前戒烟改善无症状性颈动脉狭窄患者颈动脉内膜剥脱术的结局

Preoperative smoking cessation improves carotid endarterectomy outcomes in asymptomatic carotid stenosis patients.
PubMed 文献 · J Vasc Surg · 2024-11-26

基于血管质量倡议(VQI)2013至2023年77,664例因无症状性颈动脉狭窄(ACS)行择期颈动脉内膜剥脱术(CEA)的患者,比较从不吸烟、既往吸烟(术前戒烟超过30天)与当前吸烟者的围术期及长期结局。三组围术期卒中、心肌梗死、死亡及主要不良心血管事件(MACE)无显著差异;18个月随访时既往吸烟者卒中风险低于当前吸烟者,MACE低于当前吸烟者但高于从不吸烟者。多因素Cox回归显示既往吸烟者较当前吸烟者卒中、死亡及MACE风险更低,与从不吸烟者长期卒中风险无差异。

要点

  • 三组围术期卒中、心肌梗死、死亡及MACE发生率无显著差异。
  • 18个月随访既往吸烟者卒中0.9%低于当前吸烟者1.5%(P=.001)。
  • 既往吸烟者较当前吸烟者卒中HR 0.68、死亡HR 0.79、MACE HR 0.77。

核心结论

  • ACS患者术前戒烟较继续吸烟显著降低CEA术后卒中、死亡及MACE风险,结局更接近从不吸烟者。
  • 作者认为优化ACS患者术前状态应包括戒烟咨询,血管外科医生在鼓励戒烟中起关键作用。

研究设计与样本

  • 回顾性队列研究,数据来自血管质量倡议(VQI),纳入2013至2023年因ACS行择期CEA的全部患者。
  • 排除同侧颈动脉狭窄<70%及同期行冠状动脉旁路移植术者。
  • 按吸烟状态分为从不吸烟者、既往吸烟者(术前停止吸烟超过30天)和当前吸烟者。
  • 共77,664例患者,从不吸烟者19,416例(25%),既往吸烟者39,374例(51%),当前吸烟者18,874例(24%)。

主要发现

  • 三组围术期卒中(P=.79)、心肌梗死(P=.07)、死亡(P=.23)及MACE(P=.17)发生率相似。
  • 18个月随访时既往吸烟者与从不吸烟者卒中率相似(既往吸烟者0.9% vs 从不吸烟者0.8%;P=.92)。
  • 18个月随访时既往吸烟者卒中风险低于当前吸烟者(既往吸烟者0.9% vs 当前吸烟者1.5%;P=.001)。
  • 18个月随访时既往吸烟者MACE低于当前吸烟者(既往吸烟者11.8% vs 当前吸烟者13.2%;P=.03),但高于从不吸烟者(既往吸烟者11.8% vs 从不吸烟者8.7%;P<.001)。
  • 多因素Cox回归显示,与当前吸烟者相比,既往吸烟者卒中风险更低(HR 0.68;95%CI 0.53-0.87;P=.002)、死亡风险更低(HR 0.79;95%CI 0.74-0.84;P<.001)、MACE风险更低(HR 0.77;95%CI 0.70-0.83;P<.001)。

临床怎么用

  • 作者建议优化ACS患者术前状态应包括戒烟咨询。
  • 作者认为血管外科医生在鼓励戒烟中起关键作用,其指导可显著改善CEA术后结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Smoking cessation has been suggested as having the potential to improve the outcomes of carotid endarterectomy (CEA) and mitigate the risk of long-term stroke in patients with asymptomatic carotid stenosis (ACS). This study aims to compare the perioperative and long-term outcomes of CEA in patients with ACS across different smoking status groups. METHODS: All patients receiving an elective CEA for ACS between 2013 and 2023 were identified in the Vascular Quality Initiative (VQI). Patients with an ipsilateral carotid stenosis <70% and those receiving a concomitant coronary artery bypass graft were excluded. Patients were then classified according to their smoking status: never smokers, former smokers (defined as those who have stopped smoking more than 30 days prior to their operation), and current smokers. Patient characteristics and outcomes were compared using the χ2 or Fischer exact test as appropriate for categorical variables and the analysis of variance or Kruskal-Wallis test as appropriate for continuous variables. Cox regression analysis was used to study the association between smoking status and the primary outcomes of long-term stroke and major adverse cardiac events (MACE) defined as the composite outcome of stroke, myocardial infarction, and/or mortality. RESULTS: A total of 77,664 patients received a CEA for ACS, of which 19,416 patients (25%) were never smokers, 39,374 patients (51%) were former smokers, and 18,874 patients (24%) were current smokers. Patients in the three groups had similar rates of perioperative stroke (P = .79), myocardial infarction (P = .07), mortality (P = .23), and MACE (P = .17). At 18-month follow-up, former and never smokers had similar rates of stroke (former 0.9% vs never 0.8%; P = .92), with former smokers exhibiting a lower stroke risk than current smokers (former 0.9% vs current 1.5%; P = .001). At 18 months, former smokers had a significantly lower rate of MACE compared with current smokers (former 11.8% vs current 13.2%; P = .03), but a higher rate compared with never smokers (former 11.8% vs never 8.7%; P < .001). On multivariate Cox regression analysis, compared with current smokers, former smokers were independently associated with a lower risk of stroke (hazard ratio [HR], 0.68; 95% confidence interval [CI], 0.53-0.87; P = .002), mortality (HR, 0.79; 95% CI, 0.74-0.84; P < .001), and MACE (HR, 0.77; 95% CI, 0.70-0.83; P < .001). No difference in long-term stroke risk was observed between former and never smokers (HR, 1.06; 95% CI, 0.82-1.38; P = .65). CONCLUSIONS: This study demonstrates that preoperative smoking cessation in patients with ACS significantly reduces the risk of stroke, mortality, and MACE following CEA compared with continued smoking, aligning their outcomes more closely with those of never smokers. Optimizing patients with ACS prior to surgery should include smoking cessation counseling. Vascular surgeons play a critical role in encouraging smoking cessation, as their guidance can significantly improve patient outcomes following CEA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chamseddine H, Shepard A, Constantinou C, et al. Preoperative smoking cessation improves carotid endarterectomy outcomes in asymptomatic carotid stenosis patients. J Vasc Surg. 2024. PMID: 39608415. doi:10.1016/j.jvs.2024.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。